Suppr超能文献

双侧降低风险乳房切除术对乳腺癌高危患者的短期患者报告结局:一项系统评价

Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review.

作者信息

Ntowe Koumani W, Lee Michael S, Yi Victoria N, Kaplan Samantha J, Phillips Brett T, Chiba Akiko, Plichta Jennifer K

机构信息

Department of Surgery, Duke University Medical Center, Durham, NC, USA.

Division of Plastic, Oral, and Maxillofacial Surgery, Duke University, Durham, NC, USA.

出版信息

Ann Surg Oncol. 2025 Apr;32(4):2510-2525. doi: 10.1245/s10434-024-16805-5. Epub 2025 Jan 4.

Abstract

BACKGROUND

Bilateral risk-reducing mastectomies (RRMs) have been proven to decrease the risk of breast cancer in patients at high risk owing to family history or having pathogenic genetic mutations. However, few resources with consolidated data have detailed the patient experience following surgery. This systematic review features patient-reported outcomes for patients with no breast cancer history in the year after their bilateral RRM.

METHODS

The databases MEDLINE, Embase, and Scopus were used to identify studies. Studies were then evaluated by multiple authors, and their quality was assessed by using the Methodological Index for Non-Randomized Studies score.

RESULTS

Our search identified 1858 unique studies, of which 11 met our inclusion criteria. Only two of these studies included patients who did not receive postmastectomy reconstruction. The included studies were either retrospective cohort studies or prospective studies. General satisfaction with the outcome of RRM and the decision to undergo RRM was high across many of the studies, with low levels of regret. There was also a noticeable trend of improved psychosocial outcomes following RRM. For postoperative sexual well-being, body image, aesthetic satisfactions, and somatosensory function, there were a mix of positive and negative outcomes.

CONCLUSIONS

The patients who elected to manage their breast cancer risk with bilateral RRM (mostly with reconstruction) tend to be satisfied with their decision and the surgical outcomes. This may be related to decreased cancer-related anxiety. Postmastectomy psychosocial well-being tends to improve while physical health after surgery varies by patient.

摘要

背景

双侧预防性乳房切除术(RRMs)已被证明可降低因家族病史或存在致病性基因突变而处于高风险的患者患乳腺癌的风险。然而,很少有整合数据的资源详细描述患者术后的经历。本系统评价重点关注双侧RRMs术后一年无乳腺癌病史患者的患者报告结局。

方法

使用MEDLINE、Embase和Scopus数据库识别研究。然后由多位作者对研究进行评估,并使用非随机研究方法学指数评分评估其质量。

结果

我们的检索共识别出1858项独特研究,其中11项符合我们的纳入标准。这些研究中只有两项纳入了未接受乳房切除术后重建的患者。纳入的研究为回顾性队列研究或前瞻性研究。在许多研究中,患者对RRMs结局和接受RRMs决定的总体满意度较高,后悔程度较低。RRMs后心理社会结局也有明显改善的趋势。对于术后性健康、身体形象、美学满意度和躯体感觉功能,结果有正有负。

结论

选择通过双侧RRMs(大多伴有重建)来管理乳腺癌风险的患者往往对自己的决定和手术结局感到满意。这可能与癌症相关焦虑的减轻有关。乳房切除术后心理社会幸福感往往会改善,而术后身体健康因患者而异。

相似文献

2
Risk-reducing mastectomy for the prevention of primary breast cancer.
Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD002748. doi: 10.1002/14651858.CD002748.pub4.
3
Quality of life among patients after bilateral prophylactic mastectomy: a systematic review of patient-reported outcomes.
Qual Life Res. 2016 Jun;25(6):1409-21. doi: 10.1007/s11136-015-1181-6. Epub 2015 Nov 14.
4
Prophylactic mastectomy for the prevention of breast cancer.
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
5
A systematic review of women's satisfaction and regret following risk-reducing mastectomy.
Patient Educ Couns. 2017 Dec;100(12):2182-2189. doi: 10.1016/j.pec.2017.06.032. Epub 2017 Jul 1.
9
Implants versus autologous tissue flaps for breast reconstruction following mastectomy.
Cochrane Database Syst Rev. 2024 Oct 31;10(10):CD013821. doi: 10.1002/14651858.CD013821.pub2.

本文引用的文献

1
Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2024 Dec;31(13):8813-8820. doi: 10.1245/s10434-024-16143-6. Epub 2024 Sep 4.
2
Demographics and Clinical Decision Making in Patients with Germline Moderate Penetrance Non-BRCA Mutations in Breast Cancer Related Genes.
Ann Surg Oncol. 2024 Oct;31(11):7290-7300. doi: 10.1245/s10434-024-15793-w. Epub 2024 Jul 8.
3
Clinical genetics in breast cancer.
J Surg Oncol. 2024 Jul;130(1):16-22. doi: 10.1002/jso.27630. Epub 2024 Apr 1.
4
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
J Natl Compr Canc Netw. 2023 Oct;21(10):1000-1010. doi: 10.6004/jnccn.2023.0051.
5
BRCA1/2 mutation carriers & risk reducing mastectomy: Who undergoes surgery and potential benefits.
Am J Surg. 2024 Jan;227:146-152. doi: 10.1016/j.amjsurg.2023.10.011. Epub 2023 Oct 5.
6
Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making.
Ann Surg Oncol. 2024 Jan;31(1):325-334. doi: 10.1245/s10434-023-14394-3. Epub 2023 Oct 9.
8
Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.
Am J Obstet Gynecol. 2023 Oct;229(4):388-409.e4. doi: 10.1016/j.ajog.2023.03.045. Epub 2023 Apr 12.
9
Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care.
Med J Aust. 2023 May 1;218(8):368-373. doi: 10.5694/mja2.51906. Epub 2023 Apr 2.
10
Oncologic Safety of Nipple-Sparing Mastectomy for Breast Cancer in BRCA Gene Mutation Carriers: Outcomes at 70 Months Median Follow-Up.
Ann Surg Oncol. 2023 Jun;30(6):3215-3222. doi: 10.1245/s10434-022-13006-w. Epub 2023 Jan 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验